Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Athersys Inc ATHXQ

Healthcare Biotechnology
Athersys, Inc. is a biotechnology company focused primarily on the field of regenerative medicine. The Company is engaged in the discovery and development of therapeutic product candidates to address unmet medical needs in multiple disease areas. Its MultiStem (invimestrocel) cell therapy, which is an allogeneic stem cell product candidate, is its lead platform product and is in late-stage... see more

Recent & Breaking News (PINL:ATHXQ)

Athersys and Chugai Enter License Agreement and Collaboration to Develop MultiStem(R) Cell Therapy for Ischemic Stroke in Japan

Thomson Reuters ONE March 2, 2015

Athersys to Host Fourth Quarter and Annual Financial Results Call

GlobeNewswire February 17, 2015

Athersys to Present at 17th Annual BIO CEO & Investor Conference

GlobeNewswire February 3, 2015

Athersys and Cell Therapy Catapult Announce Grant to Support Clinical Development of Stem Cell Therapy for Severe Acute Respiratory Condition

GlobeNewswire January 22, 2015

Athersys to Present at Biotech Showcase 2015

GlobeNewswire January 8, 2015

Athersys Finishes Enrollment of Phase 2 Study of MultiStem(R) Cell Therapy for Ischemic Stroke

GlobeNewswire December 29, 2014

Athersys Reports Third Quarter 2014 Results

GlobeNewswire November 10, 2014

Athersys to Host Third Quarter 2014 Financial Results Call

GlobeNewswire October 17, 2014

Athersys to Present at 2014 Stem Cell Meeting on the Mesa

GlobeNewswire September 29, 2014

Athersys Reports Second Quarter 2014 Results

GlobeNewswire August 11, 2014

Leading Small-Cap Stars Health Care Stock for August 11 Morning Session is Boston Therapeutics Inc (BTHE)

Equities.com August 11, 2014

The Federal Reserve Playing Analyst Damaging to Biotechnology Companies

Accesswire July 30, 2014

Aradigm Corp. (ARDM) Leads Small-Cap Stars Health Care Sector for July 22

Equities.com July 22, 2014

Athersys to Host Second Quarter 2014 Financial Results Call

GlobeNewswire July 16, 2014

Wall Street Remaining Bullish on Athersys After Interim Data on UC Trial

Accesswire June 16, 2014

Biotech Investors Need to Focus on Catalysts

Equities.com June 11, 2014

Understanding the Impact of Clinical Trials on Shareholder Value

Equities.com June 11, 2014

Athersys Reports First Quarter 2014 Results

GlobeNewswire May 8, 2014

Senators Support Regenerative Medicine Promotion Act of 2014

Accesswire April 28, 2014

Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy for Ulcerative Colitis

GlobeNewswire April 28, 2014